Suboptimal inhibition of platelet aggregation following tirofiban bolus in patients undergoing percutaneous coronary intervention for unstable angina pectoris

Am J Cardiol. 2003 Apr 1;91(7):872-5. doi: 10.1016/s0002-9149(03)00024-9.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Adrenergic beta-Antagonists / therapeutic use
  • Aged
  • Angina, Unstable / therapy*
  • Angioplasty, Balloon, Coronary
  • Cohort Studies
  • Female
  • Fibrinolytic Agents / therapeutic use
  • Heparin / therapeutic use
  • Humans
  • Infusions, Intravenous
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Nitrates / therapeutic use
  • Observer Variation
  • Platelet Aggregation / drug effects*
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Platelet Count
  • Tirofiban
  • Treatment Outcome
  • Tyrosine / analogs & derivatives
  • Tyrosine / therapeutic use*

Substances

  • Adrenergic beta-Antagonists
  • Fibrinolytic Agents
  • Nitrates
  • Platelet Aggregation Inhibitors
  • Tyrosine
  • Heparin
  • Tirofiban